trending Market Intelligence /marketintelligence/en/news-insights/trending/M43dUiJDS0tUT35U4W0hjw2 content esgSubNav
In This List

European Commission approves Advanced Accelerator's Somakit

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


European Commission approves Advanced Accelerator's Somakit

The European Commission has approved Advanced Accelerator Applications SA's SomaKit TOC.

Somakit is a kit for radiopharmaceutical preparation of gallium edotreotide solution for injection, for Positron Emission Tomography scans of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastroenteropancreatic neuroendocrine tumors for localizing primary tumors and their metastases.

The drug has 10-year orphan market exclusivity in the European territory.